Biomimetic RNA, Redefined
Pioneering the Future of Precision Medicine with Biomimetic RNA
Imagine a world where…
Of the 4000+ protein-linked diseases, we’re only scratching the surface. Over 90% remain untreated, accounting for 40% of US deaths, more than 1.5 million people annually.
Where EVERY LIFE can be saved, EVERY TREATMENT is personalized, and the IMPOSSIBLE BECOMES THE REALITY for millions of people worldwide.
BIOMIMETIC RNA – A BREAKTHROUGH IN RNA THERAPEUTICS
RNA therapeutics holds the potential to unlock treatments for these diseases, but the current solutions – synthetic RNA and traditional synthesis strategies – are far from ideal.
6.9M Americans suffer from Alzhelmer’s today
(10% of adults > 65 YRs)
90% of the 4000 Known protein-linked diseases
Remain untreatbale
40% of us deaths are caused by alzhelmer’s, heart disease.
(~1.5 million annually)
Synthetic rna’s fatal flaws
Why Traditional Approaches Aren’t Enough
LESS SOLUBLE
Chemical modifications can reduce concentration, bioavailability, and cellular uptake.
POOR PROTEIN LOADING
Bulky modifications restrict synthetic RNA from RNAi protein loading.
INCREASED CYTOTOXICTY
Many synthetic RNA are known to be cytotoxic, especially in large doses.
NON-ENZYMATIC SYNTHESIS
Costly (10x), wasteful (200 PMI/base), and inefficient (50% yield, 80% purity).
Precision medicine, perfected
Mimerigen’s Biomemtic RNA
“Because There Has to be a Better Way”
Inspired by Nature’s Intelligence
Our platform mimics natural RNA behavior, ensuring compatibility and performance inside the human body.
Advanced Synthesis
Process
Proprietary biomimetic techniques increase RNA stability and minimize immune response.
Superior Delivery &
Function
Engineered for precise targeting, reducing side effects and enhancing therapeutic results.
Scalable & Cost-
Efficient
Designed for wide application — from rare genetic disorders to mainstream treatments.
We are creating a sustainable platform with targeted applications
Application
- Therapeutics: CNS, cancer, auto-immune, ophthalmic, etc.
- Nanomaterials: Capsules, nanowires, photonic crustals, etc.
- Diagnostics: Ag, Microbiomem precisiondiagnostics, etc.
Modules
- Gene augmentatation: ASOs, siRNA, Crispr guidesm RNAI, etc.
- Macromolecular: Aptamers, ribozymes, origami, “mRNA”, etc.
- Probes: Primers, molecular beacons,m FISH probes, etc.
Platform
- Polymer: Length, chemical modification, & protein interfaces
- Methods: Synthesism monomer production, bioprocess, & scale
- Computaitonal: Structure prediction, Primer design, etc.
About Us
Our Mission
At Mimerigen we are revolutionizing the future of Precision Medicine and RNA Therapeutics with our Biomimetic RNA Platform. Our goal is to deliver a foundational molecular toolkit to help companies significantly advance their development and treatment of protein-linked diseases. We aim to solve the critical issues of scalability, cost, and stability in RNA production, enabling more effective and accessible treatments for everyone in need.
Our Story
Our Team
